Popular reports
Breakthrough Therapy Designation: Paving the Way for Innovation$499.00With the passage of the FDA Safety and Innovation Act of 2012 (FDASIA), the Breakthrough Therapy Designation (BTD) was introduced as the newest mechanism to facilitate expedited development and review. Here we provide an overview of the BTD pathway and its evolution over the past three years.
U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management$4,750.00More than 40% of people in the U.S. say they have experienced recent pain, with 8% suffering from chronic pain. Direct healthcare costs associated with the treatment of pain total nearly $300 billion annually.
Brexit and the life sciences: What lies ahead?$700.00The UK’s surprise decision to leave the EU has caused a great deal of uncertainty about the country's future, not least among those working in the UK biopharmaceutical and broader life sciences industry.
New Reports
Market Spotlight: Neuropathic Pain$16,500.00This Market Spotlight report covers the neuropathic pain market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
Clinical Trial Strategies in Biosimilar Drug Development$10,000.00As the patent cliff for many blockbuster biologic therapies is approaching, clinical development programs for biosimilar options to those therapies are emerging at a rapid pace.
Market Spotlight: Myelodysplastic Syndrome (MDS)$16,500.00This Market Spotlight report covers the myelodysplastic syndrome market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com